文献速递肾移植血液净化与透析

临床预测评分指导老年透析患者肾移植评估转诊

A Clinical Prediction Score to Guide Referral of Elderly Dialysis Patients for Kidney Transplant Evaluation.
PubMed 文献 · Kidney Int Rep · 2017-03-01

研究基于美国肾脏数据系统2006-2009年≥70岁新发透析患者,开发并验证一个临床预测评分,用于识别预期5年生存超过5年、适合肾移植的老年透析患者。评分在验证队列中显示最低风险组5年死亡率为47%,最高风险组超过90%。该评分可帮助医生识别潜在合适的肾移植候选者。

要点

  • 年龄>80岁、BMI<18、心衰、COPD、卧床及机构化养老预测5年死亡风险高。
  • 非白人种族、非糖尿病为ESRD原发病、透析启动6个月内就业及AVF透析启动与5年生存改善相关。
  • 最低风险组5年死亡率47%,最高风险组超过90%,评分可用于筛选转诊。

核心结论

  • 该临床预测评分可帮助医生识别适合肾移植的老年透析患者。

研究设计与样本

  • 回顾性队列研究,使用美国肾脏数据系统2006-2009年≥70岁新发透析患者,分为推导队列和验证队列。

主要发现

  • 预测5年死亡率的最强因素包括年龄>80岁、BMI<18、充血性心力衰竭、COPD、卧床及机构化养老。
  • 与5年生存改善相关的因素包括非白人种族、非糖尿病为ESRD原发病、透析启动6个月内就业及AVF透析启动。
  • 验证队列中最低风险组(占3.6%)5年死亡率为47%,最高风险组(占42%)5年死亡率>90%。

关键数值与推荐

  • 年龄>80岁、BMI<18、存在充血性心力衰竭、COPD、卧床、机构化养老预测5年死亡风险高。
  • 非白人种族、ESRD原发病非糖尿病、透析启动6个月内就业、AVF透析启动与5年生存改善相关。
  • 最低风险评分组5年死亡率为47%,最高风险评分组5年死亡率>90%。

临床怎么用

  • 临床可用该评分辅助识别预期5年生存>5年的老年透析患者,指导肾移植评估转诊。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Dialysis patients aged ≥70 years derive improved life expectancy through kidney transplantation compared to their waitlisted counterparts, but guidelines are not clear about how to identify appropriate transplantation candidates. We developed a clinical prediction score to identify elderly dialysis patients with expected 5-year survival appropriate for kidney transplantation (>5 years). METHODS: Incident dialysis patients in 2006-2009 aged ≥70 were identified from the United States Renal Data System database and divided into derivation and validation cohorts. Using the derivation cohort, candidate variables with a significant crude association with 5-year all-cause mortality were included in a multivariable logistic regression model to generate a scoring system. The scoring system was tested in the validation cohort and a cohort of elderly transplant recipients. RESULTS: Characteristics most predictive of 5-year mortality included age >80, body mass index (BMI) <18, the presence of congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), immobility, and being institutionalized. Factors associated with increased 5-year survival were non-white race, a primary cause of end stage renal disease (ESRD) other than diabetes, employment within 6 months of dialysis initiation, and dialysis start via arteriovenous fistula (AVF). 5-year mortality was 47% for the lowest risk score group (3.6% of the validation cohort) and >90% for the highest risk cohort (42% of the validation cohort). CONCLUSION: This clinical prediction score could be useful for physicians to identify potentially suitable candidates for kidney transplantation.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Chen LX, Josephson MA, Hedeker D, et al. A Clinical Prediction Score to Guide Referral of Elderly Dialysis Patients for Kidney Transplant Evaluation. Kidney Int Rep. 2017. PMID: 28845472. doi:10.1016/j.ekir.2017.02.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。